Steven L Eliason
Overview
Explore the profile of Steven L Eliason including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
601
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sweat M, Sweat Y, Yu W, Su D, Leonard R, Eliason S, et al.
Stem Cells
. 2021 Feb;
39(6):761-775.
PMID: 33529466
The murine lower incisor ectodermal organ contains a single epithelial stem cell (SC) niche that provides epithelial progenitor cells to the continuously growing rodent incisor. The dental stem cell niche...
2.
Van den Bergh F, Eliason S, Burmeister B, Giudice G
Exp Dermatol
. 2012 Jul;
21(8):605-11.
PMID: 22775995
Collagen XVII (COL17), a transmembrane protein expressed in epidermal keratinocytes (EK), is targeted by pathogenic autoantibodies in bullous pemphigoid. Treatment of EK with anti-COL17 autoantibodies triggers the production of proinflammatory...
3.
Eliason S, Stein C, Mao Q, Tecedor L, Ding S, Gaines D, et al.
J Neurosci
. 2007 Sep;
27(37):9826-34.
PMID: 17855597
Juvenile neuronal ceroid lipofuscinosis is a severe inherited neurodegenerative disease resulting from mutations in CLN3 (ceroid-lipofuscinosis, neuronal 3, juvenile). CLN3 function, and where and when it is expressed during development,...
4.
Harper S, Staber P, He X, Eliason S, Martins I, Mao Q, et al.
Proc Natl Acad Sci U S A
. 2005 Apr;
102(16):5820-5.
PMID: 15811941
Huntington's disease (HD) is a fatal, dominant neurogenetic disorder. HD results from polyglutamine repeat expansion (CAG codon, Q) in exon 1 of HD, conferring a toxic gain of function on...
5.
Xia H, Mao Q, Eliason S, Harper S, Martins I, Orr H, et al.
Nat Med
. 2004 Jul;
10(8):816-20.
PMID: 15235598
The dominant polyglutamine expansion diseases, which include spinocerebellar ataxia type 1 (SCA1) and Huntington disease, are progressive, untreatable, neurodegenerative disorders. In inducible mouse models of SCA1 and Huntington disease, repression...